Online first
Original Article
Published online: 2023-06-20

open access

Page views 721
Article views/downloads 332
Get Citation

Connect on Social Media

Connect on Social Media

The role of stress hyperglycemia and hyperlactatemia in non-diabetic patients with myocardial infarction treated with percutaneous coronary intervention

Michał Terlecki1, Maryla Kocowska-Trytko1, Christopher Pavlinec1, Aleksandra Ostrowska1, Paweł Lis1, Adam Bednarski1, Wiktoria Wojciechowska1, Katarzyna Stolarz-Skrzypek1, Marek Rajzer1


Background: Stress hyperglycemia and lactates have been used separately as markers of a severe clinical condition and poor outcomes in patients with myocardial infarction (MI). However, the interplay between glucose and lactate metabolism in patients with MI have not been sufficiently studied. The aim in the present study was to examine the relationship of glycemia on admission (AG) and lactate levels and their impact on the outcome in non-diabetic MI patients treated with percutaneous coronary intervention (PCI). 

Methods: A total of 405 consecutive, non-diabetic, MI patients were enrolled in this retrospective, observational, single-center study. Clinical characteristic including glucose and lactate levels on admission and at 30-day mortality were assessed.

Results: Patients with stress hyperglycemia (AG ≥ 7.8 mmol/L, n = 103) had higher GRACE score (median [interquartile range]: 143.4 (115.4–178.9) vs. 129.4 (105.7–154.5), p = 0.002) than normoglycemic patients (AG level < 7.8 mmol/L, n = 302). A positive correlation of AG with lactate level (R = 0.520, p < 0.001) was observed. The coexistence of both hyperglycemia and hyperlactatemia (lactate level ≥ 2.0 mmol/L) was associated with lower survival rate in the Kaplan-Meier estimates (p < 0.001). In multivariable analysis both hyperglycemia and hyperlactatemia were related to a higher risk of death at 30-day follow-up (hazard ratio [HR] 3.21, 95%, confidence interval [CI] 1.04–9.93; p = 0.043 and HR 7.08; 95% CI 1.44-34.93; p = 0.016, respectively)

Conclusions: There is a relationship between hyperglycemia and hyperlactatemia in non-diabetic MI patients treated with PCI. The coexistence of both hyperglycemia and hyperlactatemia is associated with lower survival rate and are independent predictors of 30-day mortality in MI patients and these markers should be evaluated simultaneously.

Article available in PDF format

View PDF Download PDF file


  1. Godinjak A, Iglica A, Burekovic A, et al. Hyperglycemia in critically ill patients: management and prognosis. Med Arch. 2015; 69(3): 157–160.
  2. Falciglia M, Freyberg RW, Almenoff PL, et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009; 37(12): 3001–3009.
  3. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002; 87(3): 978–982.
  4. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003; 78(12): 1471–1478.
  5. Whitcomb BW, Pradhan EK, Pittas AG, et al. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med. 2005; 33(12): 2772–2777.
  6. Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004; 56(5): 1058–1062.
  7. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery. 2000; 46(2): 335–42; discussion 342.
  8. Little RA, Frayn KN, Randall PE, et al. Plasma catecholamines in the acute phase of the response to myocardial infarction. Arch Emerg Med. 1986; 3(1): 20–27.
  9. Finfer S, Chittock DR, Su SYS, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360(13): 1283–1297.
  10. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355(9206): 773–778.
  11. Sanjuán R, Núñez J, Blasco ML, et al. Prognostic implications of stress hyperglycemia in acute ST elevation myocardial infarction. Prospective observational study. Rev Esp Cardiol. 2011; 64(3): 201–207.
  12. Angeli F, Verdecchia P, Karthikeyan G, et al. New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis. Curr Diabetes Rev. 2010; 6(2): 102–110.
  13. Dziewierz A, Giszterowicz D, Siudak Z, et al. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Clin Res Cardiol. 2010; 99(11): 715–721.
  14. Sala J, Masiá R, González de Molina FJ, et al. Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission. J Epidemiol Community Health. 2002; 56(9): 707–712.
  15. Gasior M, Stasik-Pres G, Pres D, et al. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kardiol Pol. 2007; 65(9): 1031–8; discussion 1039.
  16. Jansen TC, van Bommel J, Bakker J. Blood lactate monitoring in critically ill patients: a systematic health technology assessment. Crit Care Med. 2009; 37(10): 2827–2839.
  17. Shapiro NI, Howell MD, Talmor D, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005; 45(5): 524–528.
  18. Revelly JP, Tappy L, Martinez A, et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med. 2005; 33(10): 2235–2240.
  19. Howell MD, Donnino M, Clardy P, et al. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med. 2007; 33(11): 1892–1899.
  20. Attanà P, Lazzeri C, Picariello C, et al. Lactate and lactate clearance in acute cardiac care patients. Eur Heart J Acute Cardiovasc Care. 2012; 1(2): 115–121.
  21. Frydland M, Møller JE, Wiberg S, et al. Lactate is a prognostic factor in patients admitted with suspected st-elevation myocardial infarction. Shock. 2019; 51(3): 321–327.
  22. Lazzeri C, Valente S, Chiostri M, et al. Lactate in the acute phase of ST-elevation myocardial infarction treated with mechanical revascularization: a single-center experience. Am J Emerg Med. 2012; 30(1): 92–96.
  23. Vermeulen RP, Hoekstra M, Nijsten MWn, et al. Clinical correlates of arterial lactate levels in patients with ST-segment elevation myocardial infarction at admission: a descriptive study. Crit Care. 2010; 14(5): R164.
  24. Barth E, Albuszies G, Baumgart K, et al. Glucose metabolism and catecholamines. Crit Care Med. 2007; 35(9 Suppl): S508–S518.
  25. Kaukonen KM, Bailey M, Egi M, et al. Stress hyperlactatemia modifies the relationship between stress hyperglycemia and outcome: a retrospective observational study. Crit Care Med. 2014; 42(6): 1379–1385.
  26. Freire Jorge P, Wieringa N, de Felice E, et al. The association of early combined lactate and glucose levels with subsequent renal and liver dysfunction and hospital mortality in critically ill patients. Crit Care. 2017; 21(1): 218.
  27. Chen X, Bi J, Zhang J, et al. The impact of serum glucose on the predictive value of serum lactate for hospital mortality in critically ill surgical patients. Dis Markers. 2019; 2019: 1578502.
  28. Green JP, Berger T, Garg N, et al. Hyperlactatemia affects the association of hyperglycemia with mortality in nondiabetic adults with sepsis. Acad Emerg Med. 2012; 19(11): 1268–1275.
  29. Sotello D, Yang S, Nugent K. Glucose and lactate levels at admission as predictors of in-hospital mortality. Cureus. 2019; 11(10): e6027.
  30. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119–177.
  31. Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021; 42: 1289–1367.
  32. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145: 247–254.
  33. Fox KAA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006; 333(7578): 1091.
  34. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987; 76(1): 142–154.
  35. Hosmer D, Lamesow S. Applied survival analysis: regression modeling of time-to-event data. John Wiley & Sons, New York, NY 1999.
  36. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006; 12(4): 315–321.
  37. Lombardi AM, Fabris R, Bassetto F, et al. Hyperlactatemia reduces muscle glucose uptake and GLUT-4 mRNA while increasing (E1alpha)PDH gene expression in rat. Am J Physiol. 1999; 276(5): E922–E929.
  38. Choi CS, Kim YB, Lee FN, et al. Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling. Am J Physiol Endocrinol Metab. 2002; 283(2): E233–E240.
  39. Richards JE, Scalea TM, Mazzeffi MA, et al. Does lactate affect the association of early hyperglycemia and multiple organ failure in severely injured blunt trauma patients? Anesth Analg. 2018; 126(3): 904–910.
  40. Aslanger EK, Yıldırımtürk Ö, Şimşek B, et al. DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT Study). Int J Cardiol Heart Vasc. 2020; 30: 100603.
  41. Schmitt C, Lehmann G, Schmieder S, et al. Diagnosis of acute myocardial infarction in angiographically documented occluded infarct vessel : limitations of ST-segment elevation in standard and extended ECG leads. Chest. 2001; 120(5): 1540–1546.
  42. Mazlan ZM, Ismail AHM, Ali S, et al. Efficacy and safety of the point-of-care procalcitonin test for determining the antibiotic treatment duration in patients with ventilator-associated pneumonia in the intensive care unit: a randomised controlled trial. Anaesthesiol Intensive Ther. 2021; 53(3): 207–214.
  43. Steinfelder-Visscher J, Weerwind PW, Teerenstra S, et al. Reliability of point-of-care hematocrit, blood gas, electrolyte, lactate and glucose measurement during cardiopulmonary bypass. Perfusion. 2006; 21(1): 33–37.
  44. Rossi AF, Khan DM, Hannan R, et al. Goal-directed medical therapy and point-of-care testing improve outcomes after congenital heart surgery. Intensive Care Med. 2005; 31(1): 98–104.